Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inborn errors of apolipoprotein A-I metabolism: implications for disease, research and development
Paolo Zanoni, Arnold von Eckardstein
Current Opinion in Lipidology (2020) Vol. 31, Iss. 2, pp. 62-70
Closed Access | Times Cited: 23

Showing 23 citing articles:

A Modern Approach to Dyslipidemia
Amanda J. Berberich, Robert A. Hegele
Endocrine Reviews (2021) Vol. 43, Iss. 4, pp. 611-653
Open Access | Times Cited: 283
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research
Anand Rohatgi, Marit Westerterp, Arnold von Eckardstein, et al.
Circulation (2021) Vol. 143, Iss. 23, pp. 2293-2309
Open Access | Times Cited: 213
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Tomonori Okamura, Kazuhisa Tsukamoto, Hidenori Arai, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 31, Iss. 6, pp. 641-853
Open Access | Times Cited: 136
Cholesterol transport and beyond: Illuminating the versatile functions of HDL apolipoproteins through structural insights and functional implications
Aishwarya Sudam Bhale, Olivier Meilhac, Christian Lefebvre d’Hellencourt, et al.
BioFactors (2024) Vol. 50, Iss. 5, pp. 922-956
Open Access | Times Cited: 5
An unusual phenotype of hereditary AApoAI amyloidosis caused by a novel Asp20Tyr substitution is linked to pH-dependent aggregation of apolipoprotein A-I
Tatiana Prokaeva, Shobini Jayaraman, Elena S. Klimtchuk, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167820-167820
Closed Access
Apolipoprotein A1 deficiency increases Macrophage Apoptosis and Necrotic Core Development in Atherosclerotic Plaques in a Bim dependent manner
Alexander S. Qian, George Eduardo Gabriel Kluck, Pei Yu, et al.
Journal of Lipid Research (2025), pp. 100782-100782
Open Access
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport
Paul N. Durrington, Bilal Bashir, Bilal Bashir
Antioxidants (2025) Vol. 14, Iss. 4, pp. 430-430
Open Access
Current Diagnosis and Management of Tangier Disease
Masahiro Koseki, Shizuya Yamashita, Masatsune Ogura, et al.
Journal of Atherosclerosis and Thrombosis (2021) Vol. 28, Iss. 8, pp. 802-810
Open Access | Times Cited: 16
Dynamic protein structures in normal function and pathologic misfolding in systemic amyloidosis
Emily Lewkowicz, Olga Gursky
Biophysical Chemistry (2021) Vol. 280, pp. 106699-106699
Open Access | Times Cited: 12
Delineating the impact of pathogenic mutations on the conformational dynamics of HDL’s vital protein ApoA1: a combined computational and molecular dynamic simulation approach
Aishwarya Sudam Bhale, Krishnan Venkataraman
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 24, pp. 15661-15681
Closed Access | Times Cited: 4
Nonlinearity of the Inverse Relationship between High-Density Lipoprotein (HDL) Cholesterol and Incident Cardiovascular Risk: Is It Time to Revisit the “HDL Hypothesis”?
Carl Hashem, S. Elissa Altin, John R. Guyton, et al.
Journal of clinical lipidology (2024)
Closed Access | Times Cited: 1
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies
Francesco Forte, Ilenia Calcaterra, Roberta Lupoli, et al.
European Journal of Preventive Cardiology (2020) Vol. 28, Iss. 18, pp. 1980-1990
Closed Access | Times Cited: 9
High Density Lipoproteins: Is There a Comeback as a Therapeutic Target?
Arnold von Eckardstein
Handbook of experimental pharmacology (2021), pp. 157-200
Open Access | Times Cited: 9
Genetics and regulation of HDL metabolism
Dimitris Kardassis, Efstathia Thymiakou, Angeliki Chroni
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1867, Iss. 1, pp. 159060-159060
Closed Access | Times Cited: 9
Current models of apolipoprotein A-I lipidation by adenosine triphosphate binding cassette transporter A1
Anouar Hafiane, Ioanna Gianopoulos, Mary G. Sorci‐Thomas, et al.
Current Opinion in Lipidology (2021) Vol. 33, Iss. 2, pp. 139-145
Closed Access | Times Cited: 8
Apolipoprotein genetic variants and hereditary amyloidosis
Natasha Jeraj, Robert A. Hegele, Amanda J. Berberich
Current Opinion in Lipidology (2020) Vol. 32, Iss. 2, pp. 132-140
Closed Access | Times Cited: 5
Library screening identifies commercial drugs as potential structure correctors of abnormal apolipoprotein A-I
Christina Gkolfinopoulou, Angeliki Bourtsala, Daphne N. Georgiadou, et al.
Journal of Lipid Research (2024) Vol. 65, Iss. 5, pp. 100543-100543
Open Access
Amyloidogenic 60–71 deletion/ValThr insertion mutation of apolipoprotein A-I generates a new aggregation-prone segment that promotes nucleation through entropic effects
Norihiro Namba, Takashi Ohgita, Hiroko Tamagaki-Asahina, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Novel clinical manifestations and treatment of hereditary apoA-I amyloidosis: when a good protein turns bad
Olga Gursky
Kidney International (2020) Vol. 98, Iss. 1, pp. 62-64
Open Access | Times Cited: 2
Beyond HDL-Cholesterol: The Search for Functional Biomarkers of High Density Lipoproteins
Arnold von Eckardstein
CardioMetabolic Syndrome Journal (2022) Vol. 2, Iss. 1, pp. 28-28
Closed Access | Times Cited: 1
HDL and Therapy
Ke Li, Xianwei Xie, Yansong Guo
Advances in experimental medicine and biology (2022), pp. 171-187
Closed Access | Times Cited: 1
Genetic testing in dyslipidaemia: An approach based on clinical experience
Amanda J. Berberich, Robert A. Hegele
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 37, Iss. 3, pp. 101720-101720
Closed Access | Times Cited: 1
HDL Mimetic Peptides
Jie Chen, Jiewen Liu, Baoqi Yu
Advances in experimental medicine and biology (2022), pp. 141-151
Closed Access
Page 1

Scroll to top